DK0808367T3 - Vaskulære slimhindeaddressiner samt anvendelse deraf - Google Patents

Vaskulære slimhindeaddressiner samt anvendelse deraf

Info

Publication number
DK0808367T3
DK0808367T3 DK96906504T DK96906504T DK0808367T3 DK 0808367 T3 DK0808367 T3 DK 0808367T3 DK 96906504 T DK96906504 T DK 96906504T DK 96906504 T DK96906504 T DK 96906504T DK 0808367 T3 DK0808367 T3 DK 0808367T3
Authority
DK
Denmark
Prior art keywords
madcam
primate
recombinant
proteins
relates
Prior art date
Application number
DK96906504T
Other languages
Danish (da)
English (en)
Inventor
Michael J Briskin
Douglas J Ringler
Dominic Picarella
Walter Newman
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27011628&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0808367(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/386,857 external-priority patent/US6551593B1/en
Priority claimed from US08/523,004 external-priority patent/US7750137B2/en
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Application granted granted Critical
Publication of DK0808367T3 publication Critical patent/DK0808367T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Materials For Medical Uses (AREA)
DK96906504T 1995-02-10 1996-02-12 Vaskulære slimhindeaddressiner samt anvendelse deraf DK0808367T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/386,857 US6551593B1 (en) 1995-02-10 1995-02-10 Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through α 4 β 7 and its ligands and madcam
US08/523,004 US7750137B2 (en) 1995-09-01 1995-09-01 Mucosal vascular addressins
PCT/US1996/002153 WO1996024673A1 (en) 1995-02-10 1996-02-12 Mucosal vascular addressins and uses thereof

Publications (1)

Publication Number Publication Date
DK0808367T3 true DK0808367T3 (da) 2007-11-05

Family

ID=27011628

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96906504T DK0808367T3 (da) 1995-02-10 1996-02-12 Vaskulære slimhindeaddressiner samt anvendelse deraf

Country Status (12)

Country Link
EP (1) EP0808367B1 (de)
JP (1) JP4205162B2 (de)
AT (1) ATE366809T1 (de)
AU (1) AU4986296A (de)
CA (1) CA2212702C (de)
DE (1) DE69637155T2 (de)
DK (1) DK0808367T3 (de)
ES (1) ES2290955T3 (de)
MX (1) MX9706049A (de)
NZ (1) NZ303523A (de)
PT (1) PT808367E (de)
WO (1) WO1996024673A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0948597A4 (de) * 1996-11-01 2002-07-10 Human Genome Sciences Inc Menschliches, Schleimhaut-spezifisches Addressin-Zelladhäsionsmolekül (MAdCAM-1) und dessen Spleissvarianten
WO1998051345A2 (en) * 1997-05-09 1998-11-19 The John P. Robarts Research Institute Method for dislodging infiltrated leukocytes from a tissue
AU2007201698B2 (en) * 1998-05-13 2011-10-13 Genentech, Inc. Diagnosis and treatment of hepatic disorders
US7090845B2 (en) 1998-05-13 2006-08-15 Genentech, Inc. Diagnosis and treatment of hepatic disorders
ATE424417T1 (de) * 1998-05-13 2009-03-15 Genentech Inc Diagnose und behandlung von hepatischen krankheiten
AUPR524101A0 (en) * 2001-05-25 2001-06-21 Council Of The Queensland Institute Of Medical Research, The Antigen targeting
WO2003047526A2 (en) * 2001-11-30 2003-06-12 Incyte Genomics, Inc. Cell adhesion and extracellular matrix proteins
US20070202097A1 (en) * 2003-03-10 2007-08-30 Krissansen Geoffrey W Monoclonal Antibodies That Recognise Mucosal Addressin Cell Adhesion Molecule-1 (Madcam-1), Soluble Madcam-1 And Uses Thereof
CN1812804B (zh) 2003-05-01 2013-06-12 斯克里普斯研究学院 选择性r-钙黏着蛋白拮抗剂和方法
ATE522547T1 (de) * 2004-01-09 2011-09-15 Pfizer Antikörper zu madcam
LT3530673T (lt) * 2004-09-03 2022-06-10 Genentech, Inc. Humanizuoti anti-beta7 antagonistai ir jų panaudojimas
JP2009500390A (ja) * 2005-07-08 2009-01-08 ファイザー・リミテッド 新規ＭＡｄＣＡＭ抗体
WO2007007152A2 (en) * 2005-07-11 2007-01-18 Pfizer Limited Anti-madcam antibodies to treat metastatic cancers and chloroma
MX2010012368A (es) * 2008-05-16 2010-12-06 Genentech Inc Uso de biomarcadores para evaluar un tratamiento contra trastornos inflamatorios gastrointestinales con antagonistas de beta7-integrina.
DK2704742T3 (en) 2011-05-02 2017-10-23 Millennium Pharm Inc FORMULATION FOR ANTI-4-7 ANTIBODY
UA116189C2 (uk) 2011-05-02 2018-02-26 Мілленніум Фармасьютікалз, Інк. КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА
JP2017537105A (ja) 2014-11-26 2017-12-14 ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 瘻孔を伴うクローン病の治療用ベドリズマブ
US20170360926A1 (en) 2014-12-24 2017-12-21 Millennium Pharmaceuticals, Inc. PREDICTING OUTCOME OF TREATMENT WITH AN ANTI-alpha4beta7 INTEGRIN ANTIBODY
MA41636A (fr) 2015-03-06 2018-01-09 Millennium Pharm Inc Méthode de traitement de la cholangite sclérosante primitive
IL261750B1 (en) 2016-03-14 2024-03-01 Millennium Pharm Inc A method for preventing graft-versus-host disease
MX2018011025A (es) 2016-03-14 2019-01-10 Millennium Pharm Inc Metodos para tratar o prevenir la enfermedad del injerto contra huésped.
JP7069032B2 (ja) 2016-03-24 2022-05-17 ミレニアム ファーマシューティカルズ， インコーポレイテッド がん免疫治療における胃腸の免疫関連有害事象の治療方法
WO2017165742A1 (en) 2016-03-24 2017-09-28 Millennium Pharmaceuticals, Inc. Methods of treating gastrointestinal immune-related adverse events in anti-ctla4 anti-pd-1 combination treatments
MA44864A (fr) 2016-05-04 2019-03-13 Icahn School Med Mount Sinai Trithérapie pour le traitement d'une maladie intestinale inflammatoire
US11389533B2 (en) 2016-06-12 2022-07-19 Takeda Pharmaceutical Company Limited Method of treating inflammatory bowel disease
WO2018104893A1 (en) 2016-12-06 2018-06-14 Glaxosmithkline Intellectual Property Development Limited Alpha4-beta7 antibodies with incrased fcrn binding and/or half-life
WO2018200818A2 (en) 2017-04-28 2018-11-01 Millennium Pharmaceuticals, Inc. Method of treating pediatric disorders
US20190169291A1 (en) 2017-07-14 2019-06-06 Pfizer Inc. Antibodies to MAdCAM
AU2020279240A1 (en) * 2019-05-20 2021-12-23 Pandion Operations, Inc. MAdCAM targeted immunotolerance

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5675794A (en) * 1992-12-15 1994-07-04 Board Of Trustees Of The Leland Stanford Junior University Mucosal vascular addressin, dna and expression

Also Published As

Publication number Publication date
DE69637155D1 (de) 2007-08-23
JPH10513365A (ja) 1998-12-22
NZ303523A (en) 2002-02-01
JP4205162B2 (ja) 2009-01-07
CA2212702C (en) 2010-04-20
AU4986296A (en) 1996-08-27
MX9706049A (es) 1998-02-28
EP0808367B1 (de) 2007-07-11
DE69637155T2 (de) 2008-02-07
CA2212702A1 (en) 1996-08-15
EP0808367A1 (de) 1997-11-26
WO1996024673A1 (en) 1996-08-15
ES2290955T3 (es) 2008-02-16
PT808367E (pt) 2007-10-22
ATE366809T1 (de) 2007-08-15

Similar Documents

Publication Publication Date Title
DK0808367T3 (da) Vaskulære slimhindeaddressiner samt anvendelse deraf
Geiser et al. The interleukin-8-related chemotactic cytokines GRO alpha, GRO beta, and GRO gamma activate human neutrophil and basophil leukocytes
Pearse Receptors compete for adaptors found in plasma membrane coated pits.
Postlethwaite et al. Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment.
Chertov et al. Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils
Timpl et al. [47] Laminin
DE60219611T2 (de) Modifizierte annexin-proteine und verhinderung und behandlung von thrombose
US20060173162A1 (en) Bactericidak anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp)
JP2742925B2 (ja) 血栓形成抑制用治療薬組成物
JP2512453B2 (ja) 天然のコロニ−促進因子―１の精製
JP2008101026A (ja) 殺菌性／透過性が向上したタンパク質の機能領域に由来する生物学的に活性なペプチドおよびその使用
Helm et al. Blocking of passive sensitization of human mast cells and basophil granulocytes with IgE antibodies by a recombinant human epsilon-chain fragment of 76 amino acids.
JP2004043502A (ja) 新規蛋白質及びこれを使用した薬剤の製法
PT93910A (pt) Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
JPH03204896A (ja) インターフェロンレセプター細胞外断片
EP1399476B1 (de) Verwendung löslicher cytokeratin-1-fragmente in diagnostik
JP4794102B2 (ja) フィブリンのシトルリン誘導体及び慢性関節リウマチの診断又は治療のためのその使用
AU6942994A (en) Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof
EP1683866B1 (de) Deletionsmutanten des IgE-abhängigen Histamin-Releasing-Faktor (HRF) mit der Fähigkeit zur Histaminfreisetzung, HRF-bindende Peptide sowie deren Verwendung
HU226468B1 (en) Amino-terminally truncated mcp-2-as chemokine antagonists
McNaughton et al. Novel anti-inflammatory peptides based on chemokine–glycosaminoglycan interactions reduce leukocyte migration and disease severity in a model of rheumatoid arthritis
EA009414B1 (ru) Терапевтические применения вариантов хемокинов
JP2829405B2 (ja) 機能性ポリペプチド
Campistol et al. Polymerization of normal and intact β2-microglobulin as the amyloidogenic protein in dialysis-amyloidosis
Bond et al. Native and recombinant Fel dI as probes into the relationship of allergen structure to human IgE immunoreactivity